-+ 0.00%
-+ 0.00%
-+ 0.00%

Actinium Pharmaceuticals Q2 EPS $0.89 Beats $(0.21) Estimate, Sales $35.000M

Benzinga·08/12/2026 10:47:33
Listen to the news
Actinium Pharmaceuticals (AMEX:ATNM) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $(0.21) by 523.81 percent. This is a 504.55 percent increase over losses of $(0.22) per share from the same period last year. The company reported $35.000 million in sales this quarter.